John David Finley - Jun 12, 2023 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role: CEO, CFO, Director, Director
Signature: /s/ JD Finley
Stock symbol: PALI
Transactions as of: Jun 12, 2023
Transactions value $: -$1,619
Form type: 4
Date filed: 6/14/2023, 06:23 PM
Previous filing: Jun 13, 2023
Next filing: Jul 6, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PALI	Common Stock, par value $0.01	Options Exercise	$0	+3.48K	+90.31%	$0.00	7.32K	Jun 12, 2023	Direct	F1
transaction	PALI	Common Stock, par value $0.01	Tax liability	-$1.62K	-1.05K	-14.34%	$1.54	6.27K	Jun 13, 2023	Direct	F2
holding	PALI	Common Stock, par value $0.01						777	Jun 12, 2023	By FCW Investments, LLC	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PALI	Restricted Stock Units	Options Exercise		-3.48K	-8.33%		38.2K	Jun 12, 2023	Common Stock	3.48K		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
F2	Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units.
F3	Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity.
F4	This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on June 12, 2023, upon receipt of shareholder approval of the grant, and an additional 38,225 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.